These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 12502787

  • 1. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
    McIntyre TM, Pontsler AV, Silva AR, St Hilaire A, Xu Y, Hinshaw JC, Zimmerman GA, Hama K, Aoki J, Arai H, Prestwich GD.
    Proc Natl Acad Sci U S A; 2003 Jan 07; 100(1):131-6. PubMed ID: 12502787
    [Abstract] [Full Text] [Related]

  • 2. Lysophosphatidic acid induces neointima formation through PPARgamma activation.
    Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, Johnson LR, Marathe GK, McIntyre TM, Xu Y, Prestwich GD, Byun HS, Bittman R, Tigyi G.
    J Exp Med; 2004 Mar 15; 199(6):763-74. PubMed ID: 15007093
    [Abstract] [Full Text] [Related]

  • 3. Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.
    Liliom K, Tsukahara T, Tsukahara R, Zelman-Femiak M, Swiezewska E, Tigyi G.
    Biochim Biophys Acta; 2006 Dec 15; 1761(12):1506-14. PubMed ID: 17092771
    [Abstract] [Full Text] [Related]

  • 4. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
    Simon MF, Daviaud D, Pradère JP, Grès S, Guigné C, Wabitsch M, Chun J, Valet P, Saulnier-Blache JS.
    J Biol Chem; 2005 Apr 15; 280(15):14656-62. PubMed ID: 15710620
    [Abstract] [Full Text] [Related]

  • 5. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
    Davies SS, Pontsler AV, Marathe GK, Harrison KA, Murphy RC, Hinshaw JC, Prestwich GD, Hilaire AS, Prescott SM, Zimmerman GA, McIntyre TM.
    J Biol Chem; 2001 May 11; 276(19):16015-23. PubMed ID: 11279149
    [Abstract] [Full Text] [Related]

  • 6. Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1.
    Stapleton CM, Mashek DG, Wang S, Nagle CA, Cline GW, Thuillier P, Leesnitzer LM, Li LO, Stimmel JB, Shulman GI, Coleman RA.
    PLoS One; 2011 Apr 20; 6(4):e18932. PubMed ID: 21533082
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
    Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K.
    J Biol Chem; 1999 Sep 24; 274(39):27776-85. PubMed ID: 10488122
    [Abstract] [Full Text] [Related]

  • 8. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE.
    Mol Endocrinol; 2003 Dec 24; 17(12):2477-93. PubMed ID: 14525954
    [Abstract] [Full Text] [Related]

  • 9. Lysophosphatidic acid signaling regulates the KLF9-PPARγ axis in human induced pluripotent stem cell-derived neurons.
    Tsukahara T, Yamagishi S, Matsuda Y, Haniu H.
    Biochem Biophys Res Commun; 2017 Sep 09; 491(1):223-227. PubMed ID: 28716732
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
    Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK.
    J Clin Invest; 2000 Aug 09; 106(4):523-31. PubMed ID: 10953027
    [Abstract] [Full Text] [Related]

  • 12. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization.
    Jin Y, Knudsen E, Wang L, Maghazachi AA.
    Eur J Immunol; 2003 Aug 09; 33(8):2083-9. PubMed ID: 12884281
    [Abstract] [Full Text] [Related]

  • 13. Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.
    Tsukahara T, Matsuda Y, Haniu H.
    Int J Mol Sci; 2017 Dec 16; 18(12):. PubMed ID: 29258184
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM, Waxman DJ.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):275-84. PubMed ID: 15364543
    [Abstract] [Full Text] [Related]

  • 15. Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid.
    Erickson JR, Wu JJ, Goddard JG, Tigyi G, Kawanishi K, Tomei LD, Kiefer MC.
    J Biol Chem; 1998 Jan 16; 273(3):1506-10. PubMed ID: 9430689
    [Abstract] [Full Text] [Related]

  • 16. Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
    Cheng Y, Makarova N, Tsukahara R, Guo H, Shuyu E, Farrar P, Balazs L, Zhang C, Tigyi G.
    Cell Signal; 2009 Dec 16; 21(12):1874-84. PubMed ID: 19709640
    [Abstract] [Full Text] [Related]

  • 17. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A, Sinomiya J, Kishimoto S, Tanaka T, Kogure K, Sugiura T, Satouchi K, Waku K, Fukuzawa K.
    Biochem J; 2002 Aug 01; 365(Pt 3):617-28. PubMed ID: 11982483
    [Abstract] [Full Text] [Related]

  • 18. LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells.
    Gustin C, Van Steenbrugge M, Raes M.
    Am J Physiol Cell Physiol; 2008 Oct 01; 295(4):C905-14. PubMed ID: 18632732
    [Abstract] [Full Text] [Related]

  • 19. Lysophosphatidic acid receptor signaling in mammalian retinal pigment epithelial cells.
    Thoreson WB, Ryan JS, Shi C, Kelly ME, Bryson EJ, Toews ML, Ediger TL, Chacko DM.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2450-61. PubMed ID: 12091450
    [Abstract] [Full Text] [Related]

  • 20. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.
    Hecht JH, Weiner JA, Post SR, Chun J.
    J Cell Biol; 1996 Nov 01; 135(4):1071-83. PubMed ID: 8922387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.